Shirley Ryan AbilityLab
Chicago, Illinois, 60611, United States
NCT Number: NCT04280484
The overall objective of this project is to investigate the effectiveness of Acute Intermittent Hypoxia (AIH), to improve muscle strength and activity level in individuals with relapsing-remitting MS.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Chicago, Illinois, 60611, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
1 minute of 9% oxygen in the inspired air, alternating with 1 minute of 21% oxygen; for a total of 15 iterations/episodes.
1 minute of 21% oxygen in the inspired air, alternating with 1 minute of 21% oxygen; for a total of 15 iterations/episodes.
Time frame: 60 minutes post-intervention
Maximum isometric ankle plantar-flexion and dorsi-flexion torque using a Biodex
Time frame: 60 minutes post-intervention
Plantar-flexor and Dorsi-flexor electromyogram activity
Time frame: 60 minutes post-intervention
The symbol-digit modalities test (SDMT) is a symbol substitution neuropsychological test that examines a person's attention and speed of processing
Shirley Ryan AbilityLab
Other
Evaluating the Use of Acute Intermittent Hypoxia to Improve Symptoms in Persons With Multiple Sclerosis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03963375
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
St Louis, Missouri, United States
View Trial DetailsNCT04972929
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Birmingham, Alabama, United States
View Trial DetailsNCT03497468
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
View Trial DetailsNCT03768648
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Bordeaux, France
View Trial Details